SARS-CoV-2 seroprevalence in the Vatican City State

doi:10.1016/j.ejim.2021.01.029

. 2021 Apr:86:98-99.

doi: 10.1016/j.ejim.2021.01.029. Epub 2021 Feb 4.

SARS-CoV-2 seroprevalence in the Vatican City State

Massimo Ralli¹, Andrea Arcangeli², Paolo Maurizio Soave², Maria Cristina Voglino³, Fabio De-Giorgio⁴

Affiliations

¹ Department of Sense Organs, Sapienza University of Rome, Italy; Directorate of Health and Hygiene, Vatican City State. Electronic address: massimo.ralli@uniroma1.it.
² Directorate of Health and Hygiene, Vatican City State; Department of Anesthesiology, Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
³ Directorate of Health and Hygiene, Vatican City State.
⁴ Directorate of Health and Hygiene, Vatican City State; Department of Health Care Surveillance and Bioethics, section of Legal Medicine, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

PMID: 33581980
PMCID: PMC7859713
DOI: 10.1016/j.ejim.2021.01.029

SARS-CoV-2 seroprevalence in the Vatican City State

Massimo Ralli et al. Eur J Intern Med. 2021 Apr.

. 2021 Apr:86:98-99.

doi: 10.1016/j.ejim.2021.01.029. Epub 2021 Feb 4.

Authors

Massimo Ralli¹, Andrea Arcangeli², Paolo Maurizio Soave², Maria Cristina Voglino³, Fabio De-Giorgio⁴

Affiliations

¹ Department of Sense Organs, Sapienza University of Rome, Italy; Directorate of Health and Hygiene, Vatican City State. Electronic address: massimo.ralli@uniroma1.it.
² Directorate of Health and Hygiene, Vatican City State; Department of Anesthesiology, Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
³ Directorate of Health and Hygiene, Vatican City State.
⁴ Directorate of Health and Hygiene, Vatican City State; Department of Health Care Surveillance and Bioethics, section of Legal Medicine, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

PMID: 33581980
PMCID: PMC7859713
DOI: 10.1016/j.ejim.2021.01.029

No abstract available

Keywords: COVID-19; SARS-CoV-2; Seroprevalence; Vatican city state.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflict of interest.

Figures

**Fig. 1**
A) Total antibody index in the study population. The average antibody index was 6.43 for positive subjects and 0.44 for negative subjects. Dotted line indicates threshold for positive antibody index. B) Comparison of the total COVID-19 cases both at nasopharyngeal swab test (PCR) and serological test (Serology) in the Vatican City State from February 21, 2020 to January 4, 2021.

See this image and copyright information in PMC

Cited by

Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.
Lombardi F, Ricci R, Belmonti S, Fabbiani M, Borghetti A, Baldin G, Ciccullo A, Tamburrini E, Visconti E, Sanguinetti M, Di Giambenedetto S. Lombardi F, et al. Diagnostics (Basel). 2021 Jun 24;11(7):1154. doi: 10.3390/diagnostics11071154. Diagnostics (Basel). 2021. PMID: 34202510 Free PMC article.
Prevalence of SARS-CoV-2 Antibodies in Kosovo-Wide Population-Based Seroepidemiological Study.
Ramadani N, Hoxha-Gashi S, Gexha-Bunjaku D, Kalaveshi A, Jakupi X, Humolli I, Vaughan A, Pebody R, Kacaniku-Gunga P, Jashari V. Ramadani N, et al. Influenza Other Respir Viruses. 2024 Sep;18(9):e70004. doi: 10.1111/irv.70004. Influenza Other Respir Viruses. 2024. PMID: 39225019 Free PMC article.

References

1. https://coronavirus.jhu.edu/map.html. John Hopkins University. 2020.
1. Douma M., Imprialos K.P., Patoulias D., Katsimardou A., Stavropoulos K. COVID-19: the Waterloo of governments, healthcare systems, and large health organizations. Eur J Intern Med. 2020;77:153–155. - PMC - PubMed
1. Fontanet A., Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583–584. - PMC - PubMed
1. Jeyanathan M., Afkhami S., Smaill F., Miller M.S., Lichty B.D., Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–632. - PMC - PubMed
1. Ozisik L., Tanriover M.D., Rigby S., Unal S. European Federation of Internal Medicine AWG. ADVICE for a healthier life: adult Vaccination Campaign in Europe. Eur J Intern Med. 2016;33:14–20. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] https://coronavirus.jhu.edu/map.html. John Hopkins University. 2020.

[2] https://coronavirus.jhu.edu/map.html. John Hopkins University. 2020.

[3] Douma M., Imprialos K.P., Patoulias D., Katsimardou A., Stavropoulos K. COVID-19: the Waterloo of governments, healthcare systems, and large health organizations. Eur J Intern Med. 2020;77:153–155. - PMC - PubMed

[4] Douma M., Imprialos K.P., Patoulias D., Katsimardou A., Stavropoulos K. COVID-19: the Waterloo of governments, healthcare systems, and large health organizations. Eur J Intern Med. 2020;77:153–155. - PMC - PubMed

[5] Fontanet A., Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583–584. - PMC - PubMed

[6] Fontanet A., Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583–584. - PMC - PubMed

[7] Jeyanathan M., Afkhami S., Smaill F., Miller M.S., Lichty B.D., Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–632. - PMC - PubMed

[8] Jeyanathan M., Afkhami S., Smaill F., Miller M.S., Lichty B.D., Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–632. - PMC - PubMed

[9] Ozisik L., Tanriover M.D., Rigby S., Unal S. European Federation of Internal Medicine AWG. ADVICE for a healthier life: adult Vaccination Campaign in Europe. Eur J Intern Med. 2016;33:14–20. - PubMed

[10] Ozisik L., Tanriover M.D., Rigby S., Unal S. European Federation of Internal Medicine AWG. ADVICE for a healthier life: adult Vaccination Campaign in Europe. Eur J Intern Med. 2016;33:14–20. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 seroprevalence in the Vatican City State

Affiliations

SARS-CoV-2 seroprevalence in the Vatican City State

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous